Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
about
Stabilizing Agents for Drug Nanocrystals: Effect on BioavailabilityAngelica gigas Nakai and Soluplus-Based Solid Formulations Prepared by Hot-Melting Extrusion: Oral Absorption Enhancing and Memory Ameliorating Effects.Soluplus micelles for improving the oral bioavailability of scopoletin and their hypouricemic effect in vivoInteractions between drugs and polymers influencing hot melt extrusion.Use of Polyvinyl Alcohol as a Solubility Enhancing Polymer for Poorly Water-Soluble Drug Delivery (Part 2)Hot Melt Extrusion: Development of an Amorphous Solid Dispersion for an Insoluble Drug from Mini-scale to Clinical Scale.Application of Soluplus to Improve the Flowability and Dissolution of Baicalein Phospholipid Complex.A recent trend of drug-nanoparticles in suspension for the application in drug delivery.Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogsFormulation Development of Spherical Crystal Agglomerates of Itraconazole for Preparation of Directly Compressible Tablets with Enhanced Bioavailability.Hot melt extruded amorphous solid dispersion of posaconazole with improved bioavailability: investigating drug-polymer miscibility with advanced characterisation.Supersaturable solid self-microemulsifying drug delivery system: precipitation inhibition and bioavailability enhancement.Pharmaceutical development of an amorphous solid dispersion formulation of elacridar hydrochloride for proof-of-concept clinical studies.Nanomicelle formulation for topical delivery of cyclosporine A into the cornea: in vitro mechanism and in vivo permeation evaluation.
P2860
Q28076633-175ACF20-CDD6-4563-BA08-C64559E4ED5BQ35542449-1B9F8FAD-A914-41A9-A4DD-62F855A3EA9FQ37688752-7180D543-FC17-4396-9FD0-68304ED221BFQ38170190-8D008E14-37DC-4E1F-B2E6-D04BB002DB72Q38619498-12416CF3-4297-4E02-8059-A5919209D724Q38619531-D390E2E3-D0E9-4761-953D-B16C696760DCQ38792924-2A7DF19B-5733-4ADF-BF6C-DE165C4C7626Q38985268-0FF0F6A5-6136-4B6C-9BC3-D234DAE090DBQ40851361-881FA00D-C3A3-4B64-BCD7-4EBE71F4408BQ41987485-91BA6CDF-8C67-4121-9653-19B252B6E4A4Q42114941-8386FE08-4223-4E97-8127-9B5DC9E6A34CQ47141833-ED161507-381D-47CF-BD82-03DC770155FBQ48384525-653074B8-E555-4A78-B8FE-BE9C86E41BE2Q54839313-F887845B-4962-4DD2-BA95-6BDC738E7E08
P2860
Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Increased dissolution and oral ...... h itraconazole nanosuspension.
@ast
Increased dissolution and oral ...... h itraconazole nanosuspension.
@en
Increased dissolution and oral ...... h itraconazole nanosuspension.
@nl
type
label
Increased dissolution and oral ...... h itraconazole nanosuspension.
@ast
Increased dissolution and oral ...... h itraconazole nanosuspension.
@en
Increased dissolution and oral ...... h itraconazole nanosuspension.
@nl
prefLabel
Increased dissolution and oral ...... h itraconazole nanosuspension.
@ast
Increased dissolution and oral ...... h itraconazole nanosuspension.
@en
Increased dissolution and oral ...... h itraconazole nanosuspension.
@nl
P2093
P1476
Increased dissolution and oral ...... h itraconazole nanosuspension.
@en
P2093
Hongxia Yu
Keru Zhang
Shenshen Yang
P304
P356
10.1016/J.EJPB.2013.03.002
P407
P433
P577
2013-04-03T00:00:00Z